Skip to content

Clinical trials

Phase 1/2 trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 1/2 Country / region: Australia Clear all

818 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20022
20033
20044
200511
200611
20075
200816
200912
201014
201111
201214
201322
201416
201527
201623
201736
201839
201940
202058
202173
202290
202358
202482
202583
202667

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed280
Recruiting245
Terminated125
Active, not recruiting108
Unknown status33
Withdrawn11
Not yet recruiting11
Enrolling by invitation3
Suspended2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bristol-Myers Squibb31
Novartis Pharmaceuticals29
AstraZeneca28
Hoffmann-La Roche28
Merck Sharp & Dohme LLC23
Pfizer19
GlaxoSmithKline15
Peter MacCallum Cancer Centre, Australia12
Eli Lilly and Company10
Amgen9

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung78
Neoplasms53
Melanoma51
Neoplasm Metastasis44
Colorectal Neoplasms39
Breast Neoplasms38
Recurrence36
Multiple Myeloma32
Lymphoma, Non-Hodgkin29
Ovarian Neoplasms29

Trials

Showing 1 to 25 of 818. Each trial links to its page on Pharma Observatory.

718 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.